Back
Ginkgo Bioworks Holdings, Inc. 10K Form
Sell
31
DNA
Ginkgo Bioworks Holdings, Inc.
Last Price:
$9.24
Seasonality Move:
-18.07%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive DNA News And Ratings
See the #1 stock for the next 7 days that we like better than DNA
DNA Financial Statistics
Sales & Book Value
| Annual Sales: | $227M |
|---|---|
| Cash Flow: | $-31.6M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $10.40 |
| Price / Book: | 0.98 |
Profitability
| EPS (TTM): | -6.22580 |
|---|---|
| Net Income (TTM): | $-339.5M |
| Gross Margin: | $137.5M |
| Return on Equity: | -50.92% |
| Return on Assets: | -25.83% |
Ginkgo Bioworks Holdings, Inc. Earnings Forecast
Key Ginkgo Bioworks Holdings, Inc. Financial Ratios
-
The Gross Profit Margin over the past 6 years for DNA is 60.55%.
-
The Selling, General & Administrative Expenses for DNA have been equal to 108.42% of Gross Profit Margin.
-
The Research & Development expenses have been 158.23% of Revenue.
-
The Net Earning history of DNA is -240.94% of Total Revenues.
-
Per Share Earnings over the last 6 years have been positive in 2 years.
Ginkgo Bioworks Holdings, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | DNA |
| Website: | ginkgo.bio |
Debt
| Debt-to-Equity Ratio: | 0.76 |
|---|---|
| Current Ratio: | 4.39 |
| Quick Ratio: | 4.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
DNA Technical Analysis vs Fundamental Analysis
Sell
31
Ginkgo Bioworks Holdings, Inc. (DNA)
is a Sell
Is Ginkgo Bioworks Holdings, Inc. a Buy or a Sell?
-
Ginkgo Bioworks Holdings, Inc. stock is rated a SellThe current Ginkgo Bioworks Holdings, Inc. [DNA] share price is $9.21. The Score for DNA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.